Recombinant Proteins Global Market Report 2024

Description

“Recombinant Proteins Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on recombinant proteins market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for recombinant proteins? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The recombinant proteins market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Antibodies; Cytokines; Immune Checkpoint Protein; Virus Antigens; Enzymes; Recombinant Regulatory Proteins; Hormones; Other Products
2) By Application: Drug And Discovery Development; Therapeutics; Research; Other Applications
3) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institute; Diagnostic Laboratories; Other End Users
Companies Mentioned: Abcam plc; Abnova Corporation; Bio-Rad Laboratoroies Inc.; Merck Co. & KGaA; R&D Systems Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Recombinant proteins are proteins that have been altered or edited using recombinant DNA technology. In this process, a plasmid is employed, containing the gene encoding the desired target protein, which is cloned downstream of a promoter region. These modified proteins find application in various fields, including pharmaceuticals, protein-based polymers for drug delivery, disease treatment through antibodies and enzymes, protein scaffolds for tissue engineering, and numerous other uses.

The primary types of recombinant protein products encompass antibodies, cytokines, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory proteins, hormones, and others. Antibodies, for example, are immune system components that circulate in the blood, identifying and neutralizing foreign objects such as bacteria and viruses. They are utilized across diverse applications, including drug and discovery development, therapeutics, research, and more. These recombinant proteins are predominantly utilized by pharmaceutical and biotechnology companies, academic and research institutes, diagnostic laboratories, and other relevant entities.

The recombinant proteins market research report is one of a series of new reports from The Business Research Company that provides recombinant proteins market statistics, including recombinant proteins industry global market size, regional shares, competitors with a recombinant proteins market share, detailed recombinant proteins market segments, market trends and opportunities, and any further data you may need to thrive in the recombinant proteins industry. The recombinant proteins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The recombinant proteins market size has grown rapidly in recent years. It will grow from $2.12 billion in 2023 to $2.37 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth observed in the historical period can be attributed to the increasing demand for biopharmaceuticals, the rising prevalence of chronic diseases, a growing aging population, government initiatives and funding, as well as the expanding applications in research and diagnostics.

The recombinant proteins market size is expected to see rapid growth in the next few years. It will grow to $3.79 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The anticipated growth in the forecast period can be attributed to the increased adoption of personalized medicine, the rapid expansion of the biotechnology sector, global initiatives to address rare diseases, advancements in protein engineering techniques, and the identification of emerging markets and untapped opportunities. Key trends expected in the forecast period include the continued expansion of personalized medicine, rapid growth in the biotechnology sector, a heightened demand for therapeutic proteins, the emergence of novel therapeutic targets, and a global focus on vaccine development.

The anticipated increase in regulatory approvals is set to drive the growth of the recombinant protein market in the future. Regulatory approvals are crucial for research involving human subjects, particularly for drugs addressing severe chronic diseases such as cancer, cardiovascular diseases, endocrine diseases, and viral diseases. In January 2022, the Centre for Drug Evaluation and Research (CDER) reported that 38 out of 50 medications authorized in 2021 received their first U.S. approval. This represents a notable increase from the previous year, with first-in-class drugs comprising 54% of the drugs approved in 2021. Therefore, the growing number of regulatory approvals is a significant factor propelling the recombinant protein market's growth.

Government initiatives in healthcare research and development are expected to contribute to the growth of the recombinant protein market. Various government authorities are undertaking specific actions and programs to support healthcare initiatives, including research into recombinant proteins. In 2022, the UK government announced £260 million in funding to boost healthcare research and manufacturing, supporting NHS-led health research, diagnostics, and treatment development. Government initiatives for research and development in healthcare play a crucial role in driving the recombinant protein market forward.

Product innovation emerges as a prominent trend in the recombinant protein market, with major companies focusing on developing cutting-edge products to enhance their market positions. For instance, ProteoGenix introduced the XtenCHO Transient CHO Expression System in March 2022, aiming to improve biologics development. This system offers significant advantages, including higher yields, optimized plasmid stability, and streamlined protocols for enhanced efficiency in bioanalytical applications and drug development.

Collaborations and partnerships are strategic initiatives undertaken by major companies in the recombinant protein market to gain a competitive edge. In October 2023, ARTES Biotechnology GmbH collaborated with Basic Pharma to establish a streamlined supply chain process for developing and producing non-GMP recombinant proteins. This collaboration focuses on expediting the time-to-market for new pharmaceutical products, showcasing the potential benefits of partnerships in fostering innovation.

In December 2021, Thermo Fisher Scientific Inc. acquired PeproTech, Inc., enhancing its capabilities in serving high-growth cells and gene therapy. Thermo Fisher's acquisition allows them to integrate PeproTech's recombinant protein portfolio into their cell culture media products, providing clients with comprehensive offerings. PeproTech Inc., a recombinant protein producer based in the United States, specializes in developing and manufacturing recombinant cytokine products for life science research.

Major companies operating in the recombinant proteins market report are Abcam plc, Abnova Corporation, Bio-Rad Laboratoroies Inc., Merck Co. & KGaA, R&D Systems Inc., Proteintech Group Inc., RayBiotech Life Inc., GenScript Biotech Corporation, Elpiscience Biopharmaceuticals Co. Ltd., Elevian Inc., Gigagen Inc., Janssen- Cilag Pvt. Ltd., Sino Biological Inc., OriGene Technologies Inc., Feldan Therapeutics Inc., Randox Laboratories Ltd., Plant Biotechnology Inc., Infinite Enzymes Inc., Bio-Techne Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Crown Bioscience Inc., Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bracco Imaging S.p.A., Cardinal Health Inc., Eli Lilly and Company, Gamma Medica Inc., LambdaSpect Ltd

North America was the largest region in the recombinant protein market in 2023. The regions covered in the recombinant proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the recombinant proteins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The recombinant protein market consists of sales of recombinant monoclonal antibodies, interferons, and interleukins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11290

1. Executive Summary

2. Recombinant Proteins Market Characteristics

3. Recombinant Proteins Market Trends And Strategies

4. Recombinant Proteins Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Recombinant Proteins Market Size and Growth

5.1. Global Recombinant Proteins Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Recombinant Proteins Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Recombinant Proteins Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Recombinant Proteins Market Segmentation

6.1. Global Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antibodies
Cytokines
Immune Checkpoint Protein
Virus Antigens
Enzymes
Recombinant Regulatory Proteins
Hormones
Other Products
6.2. Global Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Drug And Discovery Development
Therapeutics
Research
Other Applications
6.3. Global Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic And Research Institute
Diagnostic Laboratories
Other End Users

7. Recombinant Proteins Market Regional And Country Analysis

7.1. Global Recombinant Proteins Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Recombinant Proteins Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Recombinant Proteins Market

8.1. Asia-Pacific Recombinant Proteins Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Recombinant Proteins Market

9.1. China Recombinant Proteins Market Overview
9.2. China Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Recombinant Proteins Market

10.1. India Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Recombinant Proteins Market

11.1. Japan Recombinant Proteins Market Overview
11.2. Japan Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Recombinant Proteins Market

12.1. Australia Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Recombinant Proteins Market

13.1. Indonesia Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Recombinant Proteins Market

14.1. South Korea Recombinant Proteins Market Overview
14.2. South Korea Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Recombinant Proteins Market

15.1. Western Europe Recombinant Proteins Market Overview
15.2. Western Europe Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Recombinant Proteins Market

16.1. UK Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Recombinant Proteins Market

17.1. Germany Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Recombinant Proteins Market

18.1. France Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Recombinant Proteins Market

19.1. Italy Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Recombinant Proteins Market

20.1. Spain Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Recombinant Proteins Market

21.1. Eastern Europe Recombinant Proteins Market Overview
21.2. Eastern Europe Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Recombinant Proteins Market

22.1. Russia Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Recombinant Proteins Market

23.1. North America Recombinant Proteins Market Overview
23.2. North America Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Recombinant Proteins Market

24.1. USA Recombinant Proteins Market Overview
24.2. USA Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Recombinant Proteins Market

25.1. Canada Recombinant Proteins Market Overview
25.2. Canada Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Recombinant Proteins Market

26.1. South America Recombinant Proteins Market Overview
26.2. South America Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Recombinant Proteins Market

27.1. Brazil Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Recombinant Proteins Market

28.1. Middle East Recombinant Proteins Market Overview
28.2. Middle East Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Recombinant Proteins Market

29.1. Africa Recombinant Proteins Market Overview
29.2. Africa Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Recombinant Proteins Market Competitive Landscape And Company Profiles

30.1. Recombinant Proteins Market Competitive Landscape
30.2. Recombinant Proteins Market Company Profiles
- 30.2.1. Abcam plc
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Abnova Corporation
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bio-Rad Laboratoroies Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck Co. & KGaA
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. R&D Systems Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Recombinant Proteins Market Competitive Benchmarking

32. Global Recombinant Proteins Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Recombinant Proteins Market

34. Recombinant Proteins Market Future Outlook and Potential Analysis

34.1 Recombinant Proteins Market In 2028 - Countries Offering Most New Opportunities
34.2 Recombinant Proteins Market In 2028 - Segments Offering Most New Opportunities
34.3 Recombinant Proteins Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer